Abstract:A near‐infrared (NIR) light‐controlled nanosystem is developed that allows spatiotemporally controlled photodynamic therapy and further triggers the enzyme‐activated gene expression regulation in tumors. The nanosystem is constructed by upconversion nanoparticles, photosensitizer, enzyme‐activatable antisense oligonucleotide, mitochondria targeting molecules, which provide an augmented antitumor effect because of NIR light‐induced mitochondrial photodamage and enzyme‐activated gene regulation. The lack of precise spatiotemporal gene modulation and therapy impedes progress in medical applications. Herein, a 980 nm near‐infrared (NIR) light‐controlled nanoplatform, namely URMT, is developed, which can allow spatiotemporally controlled photodynamic therapy and trigger the enzyme‐activated gene expression regulation in tumors. URMT is constructed by engineering an enzyme‐activatable antisense oligonucleotide, which combined with an upconversion nanoparticle (UCNP)‐based photodynamic nanosystem, followed by the surface functionalization of triphenylphosphine (TPP), a mitochondria‐targeting ligand. URMT allows for the 980 nm NIR light‐activated generation of reactive oxygen species, which can induce the translocation of a DNA repair enzyme (namely apurinic/apyrimidinic endonuclease 1, APE1) from the nucleus to mitochondria. APE1 can recognize the basic apurinic/apyrimidinic (AP) sites in DNA double‐strands and perform cleavage, thereby releasing the functional single‐strands for gene regulation. Overall, an augmented antitumor effect is observed due to NIR light‐controlled mitochondrial damage and enzyme‐activated gene regulation. Altogether, the approach reported in this study offers high spatiotemporal precision and shows the potential to achieve precise and specific gene regulation for targeted tumor treatment.

Spatiotemporally Controllable Diphtheria Toxin Expression Using a Light-Switchable Transgene System Combining Multifunctional Nanoparticle Delivery System for Targeted Melanoma Therapy

Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology.

A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy

Spatiotemporally Controllable Diphtherin Transgene System and Neoantigen Immunotherapy.

Programing Immunogenic Cell Death in Breast Tumors with Designer DNA Frameworks

Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system

Multifunctional Amphiphilic Peptide Dendrimer As Nonviral Gene Vectors for Effective Cancer Therapy Via Combined Gene/photodynamic Therapies

Genetically Light-Enhanced Immunotherapy Mediated by a Fluorinated Reduction-Sensitive Delivery System

Spatiotemporally Controlled Pseudomonas Exotoxin Transgene System Combined with Multifunctional Nanoparticles for Breast Cancer Antimetastatic Therapy.

A Tumor Targeted Chimeric Peptide for Synergistic Endosomal Escape and Therapy by Dual‐Stage Light Manipulation

Tumor Microenvironment-Specific Chemical Internalization for Enhanced Gene Therapy of Metastatic Breast Cancer

A Tumour Mrna-Triggered Nanoassembly for Enhanced Fluorescence Imaging-Guided Photodynamic Therapy.

A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem

Red fluorescent AIEgens based multifunctional nonviral gene vectors for the efficient combination of gene therapy and photodynamic therapy in anti-cancer

A Safe, Effective in Vivo Gene Therapy for Melanoma Using Tyrosinase Promoter-Driven Cytosine Deaminase Gene

Tumor-specific transcriptional targeting of suicide gene therapy

Multifunctional “core-shell” nanoparticles-based gene delivery for treatment of aggressive melanoma

Targeted therapy for malignant cancer mediated by adenovirus vector expressing diphtheria toxin a based on loss of IGF2 imprinting

Virus-esque nucleus-targeting nanoparticles deliver trojan plasmid for release of anti-tumor shuttle protein.

Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy

Photothermal Nano-Vaccine Promoting Antigen Presentation and Dendritic Cells Infiltration for Enhanced Immunotherapy of Melanoma via Transdermal Microneedles Delivery